Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02309294 · ClinicalTrials.gov registry record · NA
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin
A NA study, sponsored by Church & Dwight Company.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT02309294: Completed NA study, sponsored by Church & Dwight Company.
NCT02309294 is a NA study that has completed, run by Church & Dwight Company. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02309294, a NA study, has completed, sponsored by Church & Dwight Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a modified primary irritancy patch test that can detect weak irritants that require multiple applications to cause a skin reaction.
Interventions
- DEVICE Novel lubricant Miami w/ fragrance
- DEVICE Novel lubricant Miami no fragrance
- DEVICE KY Liquid lubricant
- DEVICE Astroglide Gel lubricant
- DEVICE Wet Platinum lubricant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02309294
The ClinicalTrials.gov registry entry for NCT02309294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Church & Dwight Company, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Novel lubricant Miami w/ fragrance is the first listed.
NCT02309294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02309294 about?
NCT02309294 is a clinical study titled "14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin". The objective of this study is to determine the ability of the study material to cause irritation to the skin of humans under controlled patch test conditions. Substances that come into contact with human skin need to be evaluated for their propensity to irritate and/or sensitize. This testing is a ...
What is the current status of trial NCT02309294?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2014-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02309294?
The interventions under investigation include: Novel lubricant Miami w/ fragrance (DEVICE), Novel lubricant Miami no fragrance (DEVICE), KY Liquid lubricant (DEVICE), Astroglide Gel lubricant (DEVICE), Wet Platinum lubricant (DEVICE).
Who is sponsoring clinical trial NCT02309294?
This trial is sponsored by Church & Dwight Company, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.